Compare ASGI & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ASGI | PRME |
|---|---|---|
| Founded | 2019 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 693.8M | 666.1M |
| IPO Year | N/A | 2022 |
| Metric | ASGI | PRME |
|---|---|---|
| Price | $22.77 | $3.93 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $6.42 |
| AVG Volume (30 Days) | 83.3K | ★ 3.3M |
| Earning Date | 01-01-0001 | 02-27-2026 |
| Dividend Yield | ★ 8.76% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $5,977,000.00 |
| Revenue This Year | N/A | $95.64 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 647.13 |
| 52 Week Low | $14.96 | $1.11 |
| 52 Week High | $18.55 | $6.94 |
| Indicator | ASGI | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 60.13 | 48.40 |
| Support Level | $21.76 | $4.08 |
| Resistance Level | $22.80 | $4.21 |
| Average True Range (ATR) | 0.35 | 0.37 |
| MACD | 0.08 | -0.03 |
| Stochastic Oscillator | 87.87 | 20.50 |
abrdn Global Infrastructure Income Fund is a non-diversified, closed-end management investment company. Its objective is to seek to provide a high level of total return with an emphasis on current income by investing in assets that provide necessary services to society.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.